Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Anemia

Free Subscription Articles published in Lancet Retrieve available abstracts of 37 articles: HTML format

Single Articles

April 2024
1. D'ANGELO SP, Araujo DM, Abdul Razak AR, Agulnik M, et al
   Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
   Lancet. 2024;403:1460-1471.
   PubMed     Abstract available
   
   
   January 2024
2. WEST EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al
   Complement in human disease: approved and up-and-coming therapeutics.
   Lancet. 2024;403:392-405.
   PubMed     Abstract available
   
   
   December 2023
3. THE LANCET
   The promise of genetic therapies in sickle cell disease.
   Lancet. 2023;402:2265.
   PubMed    
   
   
   November 2023
4. BRADFORD DRR, Swift A, Allik M, McMahon AD, et al
   Physical health of care-experienced young children in high-income countries: a scoping review.
   Lancet. 2023;402 Suppl 1:S28.
   PubMed     Abstract available
   
   
   September 2023
5. ROBERTS I, Jones CP
   Structural racism and iron deficiency anaemia.
   Lancet. 2023;402:834-835.
   PubMed    
   
   
   July 2023
6. AGARWAL N, Azad AA, Carles J, Fay AP, et al
   Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
   Lancet. 2023;402:291-303.
   PubMed     Abstract available
   
   
   
7. DASHRAATH P, Lim KMX, Chin HL, Sidek A, et al
   Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene.
   Lancet. 2023;402:141.
   PubMed    
   
   
   June 2023
8. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
   Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
   Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
   PubMed     Abstract available
   
   
   May 2023
9. CONRAD N, Misra S, Verbakel JY, Verbeke G, et al
   Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
   Lancet. 2023 May 5:S0140-6736(23)00457-9. doi: 10.1016/S0140-6736(23)00457.
   PubMed     Abstract available
   
   
   April 2023
10. SHAND AW, Kidson-Gerber GL
    Anaemia in pregnancy: a major global health problem.
    Lancet. 2023 Apr 20:S0140-6736(23)00396-3. doi: 10.1016/S0140-6736(23)00396.
    PubMed    
    
    
    
11. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available
    
    
    
12. PEPE J, Cipriani C, Colangelo L, Minisola S, et al
    Avascular necrosis in both hips in a patient with transfusion dependent beta-thalassaemia.
    Lancet. 2023;401:e19.
    PubMed    
    
    
    January 2023
13. VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
    Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
    Lancet. 2023;401:269-280.
    PubMed     Abstract available
    
    
    
14. IKEDA K, Ueda K
    Gaining MOMENTUM against anaemic myelofibrosis.
    Lancet. 2023;401:248-249.
    PubMed    
    
    
    November 2022
15. MICHAEL M, Bagga A, Sartain SE, Smith RJH, et al
    Haemolytic uraemic syndrome.
    Lancet. 2022;400:1722-1740.
    PubMed     Abstract available
    
    
    
16. MCDONAGH TA, Bromage DI, Cannata A
    Intravenous iron passes another endurance test in heart failure.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02180.
    PubMed    
    
    
    
17. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    PubMed     Abstract available
    
    
    October 2022
18. SHIH MY, Wang JD
    Ghost cells are the spectre of fetal-maternal haemorrhage.
    Lancet. 2022;400:1223.
    PubMed    
    
    
    September 2022
19. VAN GALEN LS, Simsek S
    Chilling to the marrow: finding extramedullary haematopoiesis in an unusual location behind the xiphoid.
    Lancet. 2022;400:e9.
    PubMed    
    
    
    August 2022
20. KUO KHM, Layton DM, Lal A, Al-Samkari H, et al
    Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent alpha-thalassaemia or beta-thalassaemia: an open-label, multicentre, phase 2 study.
    Lancet. 2022;400:493-501.
    PubMed     Abstract available
    
    
    
21. KATTAMIS A
    An energy booster for thalassaemic red blood cells.
    Lancet. 2022;400:470-471.
    PubMed    
    
    
    June 2022
22. KATTAMIS A, Kwiatkowski JL, Aydinok Y
    Thalassaemia.
    Lancet. 2022;399:2310-2324.
    PubMed     Abstract available
    
    
    January 2022
23. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    PubMed    
    
    
    
24. VIGNESHWARAN J, Kumar MS, Raghavan V, Sundari S, et al
    Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Lancet. 2022;399:393.
    PubMed    
    
    
    September 2021
25. LICHTSINN HS, Weyand AC, McKinney ZJ, Wilson AM, et al
    Sickle cell trait: an unsound cause of death.
    Lancet. 2021;398:1128-1129.
    PubMed    
    
    
    
26. GURNARI C, Colak C, Zawit M, Maciejewski JP, et al
    Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria.
    Lancet. 2021;398:e14.
    PubMed    
    
    
    February 2021
27. RICHARDS T, Clevenger B, Dahly D, Besser M, et al
    Iron deficiency in PREVENTT - Authors' reply.
    Lancet. 2021;397:670.
    PubMed    
    
    
    
28. KEEGAN A, Crispin P, Ormerod A, Brown K, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:669.
    PubMed    
    
    
    
29. FROESSLER B, Murphy E, Hodyl N
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668.
    PubMed    
    
    
    
30. HOFMANN A, Gross I, Girelli D, Aapro M, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668-669.
    PubMed    
    
    
    January 2021
31. PASRICHA SR, Tye-Din J, Muckenthaler MU, Swinkels DW, et al
    Iron deficiency.
    Lancet. 2021;397:233-248.
    PubMed     Abstract available
    
    
    
32. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.
    PubMed    
    
    
    
33. CRITCHLEY HOD, Munro MG, Shakur-Still H, Roberts I, et al
    Menstruation should not be overlooked in control of anaemia.
    Lancet. 2021;397:26.
    PubMed    
    
    
    December 2020
34. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.
    PubMed    
    
    
    
35. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.
    PubMed    
    
    
    November 2020
36. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    PubMed     Abstract available
    
    
    September 2020
37. ABRAMSON JS, Palomba ML, Gordon LI, Lunning MA, et al
    Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
    Lancet. 2020;396:839-852.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.